Zhicong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhicong Wang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Mozhen Liu
Department of Orthopedics, The First Affiliated Hospital of Dalian Medical University, Dalian, China
5 shared publications- Xi Chen
Department of Orthopedics, Deyang People’s Hospital, Deyang, China
5 shared publications Qing Zhou
Department of Orthopedics, Deyang People’s Hospital, Deyang, China
3 shared publicationsBo Gao
Department of Orthopedics, Deyang People’s Hospital, Deyang, China
2 shared publicationsHailong Liu
Department of Orthopedics, People’s Hospital of Deyang City, Deyang, China
2 shared publicationsJianjun Zhang
Department of Orthopedics, People’s Hospital of Deyang City, Deyang, China
2 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Development and internal validation of prediction model for 90-day mortality in older patients with hip fracture using admission blood parameters
To develop and validate an early prediction model for short-term mortality risk in older patients with hip fracture using admission laboratory parameters.
- 5 August 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Open AccessDevelopment and internal validation of prediction model for 90-day mortality in older patients with hip fracture using admission blood parameters
To develop and validate an early prediction model for short-term mortality risk in older patients with hip fracture using admission laboratory parameters.
- 4 June 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Genetic Associations Between Common Medication Use and Osteoporosis-Related Outcomes: A Mendelian Randomization Study
Introduction: Osteoporosis pathogenesis involves a complex interplay of genetic predisposition and medication exposure. Although long-term medication use contributes to bone fragility, which is distinct from osteomalacia, genetic evidence linking common medication-use traits to osteoporosis remains limited. Material and methods: Two-sample Mendelian randomization (MR) analyses utilized GWAS data for 22 medication-use traits (UK Biobank) and osteoporosis outcomes (FinnGen R12). Multivariable MR (MVMR) was employed to adjust for confounding by underlying disease indications. Primary estimates were derived using the inverse variance–weighted (IVW) method, supported by comprehensive sensitivity analyses including MR-Egger, weighted median, and MR-PRESSO to evaluate heterogeneity and pleiotropy. Results: Univariable MR identified seven significant associations: anilide use with increased osteoporosis risk (OR=1.25, FDR=0.0201); immunosuppressant use with higher risks of osteoporosis with pathological fracture (OR=1.16, FDR=0.0074) and drug-induced osteoporosis (OR=1.36, FDR=0.0168); thyroid preparations with increased osteoporosis (OR=1.08, FDR=0.0016), drug-induced osteoporosis, and osteoporosis with pathological fracture; and an inverse association between antidiabetic drug use and osteoporosis (OR=0.88, FDR=0.0002). In MVMR, associations for anilide and thyroid preparation use remained significant after adjusting for back pain and hypothyroidism, respectively. However, the antidiabetic signal reversed after type 2 diabetes adjustment, indicating the observed benefit was likely confounded by the underlying metabolic condition rather than a direct pharmacological effect. Conclusions: Genetic evidence supports that anilide and thyroid hormone use may independently increase osteoporosis risk, while the protection from antidiabetic therapy is confounded by diabetes status. Medication-related osteoporosis should be considered in long-term pharmacologic management.
- 4 June 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Genetic Associations Between Common Medication Use and Osteoporosis-Related Outcomes: A Mendelian Randomization Study
Introduction: Osteoporosis pathogenesis involves a complex interplay of genetic predisposition and medication exposure. Although long-term medication use contributes to bone fragility, which is distinct from osteomalacia, genetic evidence linking common medication-use traits to osteoporosis remains limited. Material and methods: Two-sample Mendelian randomization (MR) analyses utilized GWAS data for 22 medication-use traits (UK Biobank) and osteoporosis outcomes (FinnGen R12). Multivariable MR (MVMR) was employed to adjust for confounding by underlying disease indications. Primary estimates were derived using the inverse variance–weighted (IVW) method, supported by comprehensive sensitivity analyses including MR-Egger, weighted median, and MR-PRESSO to evaluate heterogeneity and pleiotropy. Results: Univariable MR identified seven significant associations: anilide use with increased osteoporosis risk (OR=1.25, FDR=0.0201); immunosuppressant use with higher risks of osteoporosis with pathological fracture (OR=1.16, FDR=0.0074) and drug-induced osteoporosis (OR=1.36, FDR=0.0168); thyroid preparations with increased osteoporosis (OR=1.08, FDR=0.0016), drug-induced osteoporosis, and osteoporosis with pathological fracture; and an inverse association between antidiabetic drug use and osteoporosis (OR=0.88, FDR=0.0002). In MVMR, associations for anilide and thyroid preparation use remained significant after adjusting for back pain and hypothyroidism, respectively. However, the antidiabetic signal reversed after type 2 diabetes adjustment, indicating the observed benefit was likely confounded by the underlying metabolic condition rather than a direct pharmacological effect. Conclusions: Genetic evidence supports that anilide and thyroid hormone use may independently increase osteoporosis risk, while the protection from antidiabetic therapy is confounded by diabetes status. Medication-related osteoporosis should be considered in long-term pharmacologic management.
- Open Access
- 27 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1684738
Blood indicators for short-term mortality risk in older patients with hip fracture: association and predictive value
Objectives: To investigate blood indicators associated with short-term mortality risk in older patients with hip fracture, and further evaluate the incremental predictive value of incorporating these indicators into existing clinical models. Methods: Data from 1881 patients in our institutional hip fracture database between January 2013 and December 2023 were retrospectively analyzed. The study outcome was all-cause mortality within 90 days of admission. Stepwise logistic regression, the Boruta algorithm, and Lasso regression were performed to identify features associated with mortality risk. Following feature selection, two predictive models were developed: Model A (clinical indicators only) and Model B (both clinical and blood indicators). Predictive performance was assessed using the area under the curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: Of the 1881 patients, 217 (11.5%) died within 90 days. Stepwise logistic regression identified 12 significant features associated with mortality risk, the Boruta algorithm identified 25 important features, and Lasso regression analysis selected 18 features with non-zero coefficients (all P < 0.05). Model B significantly outperformed Model A across all feature selection methods (all P < 0.001): stepwise logistic regression (AUC: 0.822 vs. 0.753), the Boruta algorithm (AUC: 0.820 vs. 0.749), and Lasso regression (AUC: 0.826 vs. 0.756). Model B also showed significant reclassification improvements (all P < 0.001): stepwise logistic regression (NRI: 0.733, IDI: 0.107), the Boruta algorithm (NRI: 0.762, IDI: 0.113), and Lasso regression (NRI: 0.725, IDI: 0.112). Conclusion: Various blood indicators were associated with 90-day mortality in older patients with hip fracture, and significantly enhanced the predictive ability of clinical models for short-term mortality risk. By utilizing these blood indicators, clinicians can comprehensively and objectively assess the physiological status of hip fracture patients at admission, thereby facilitating the early identification of high-risk patients and guiding personalized treatment strategies.
- 27 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1684738
Open AccessBlood indicators for short-term mortality risk in older patients with hip fracture: association and predictive value
Objectives: To investigate blood indicators associated with short-term mortality risk in older patients with hip fracture, and further evaluate the incremental predictive value of incorporating these indicators into existing clinical models. Methods: Data from 1881 patients in our institutional hip fracture database between January 2013 and December 2023 were retrospectively analyzed. The study outcome was all-cause mortality within 90 days of admission. Stepwise logistic regression, the Boruta algorithm, and Lasso regression were performed to identify features associated with mortality risk. Following feature selection, two predictive models were developed: Model A (clinical indicators only) and Model B (both clinical and blood indicators). Predictive performance was assessed using the area under the curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: Of the 1881 patients, 217 (11.5%) died within 90 days. Stepwise logistic regression identified 12 significant features associated with mortality risk, the Boruta algorithm identified 25 important features, and Lasso regression analysis selected 18 features with non-zero coefficients (all P < 0.05). Model B significantly outperformed Model A across all feature selection methods (all P < 0.001): stepwise logistic regression (AUC: 0.822 vs. 0.753), the Boruta algorithm (AUC: 0.820 vs. 0.749), and Lasso regression (AUC: 0.826 vs. 0.756). Model B also showed significant reclassification improvements (all P < 0.001): stepwise logistic regression (NRI: 0.733, IDI: 0.107), the Boruta algorithm (NRI: 0.762, IDI: 0.113), and Lasso regression (NRI: 0.725, IDI: 0.112). Conclusion: Various blood indicators were associated with 90-day mortality in older patients with hip fracture, and significantly enhanced the predictive ability of clinical models for short-term mortality risk. By utilizing these blood indicators, clinicians can comprehensively and objectively assess the physiological status of hip fracture patients at admission, thereby facilitating the early identification of high-risk patients and guiding personalized treatment strategies.
- Open Access
- 22 May 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1401443
Association of systemic inflammation response index with mortality risk in older patients with hip fracture: a 10-year retrospective cohort study
Objective: With a rapidly aging global population, the assessment of mortality risk following hip fracture in older adults has received increasing attention. Recently, the system inflammation response index (SIRI) has been identified as a novel prognostic marker to reflect both systemic inflammation and immune status. However, it is not yet known whether SIRI is a potential predictor of subsequent death in hip fracture patients. Therefore, this study aimed to investigate the association between SIRI and mortality in older patients with hip fracture.Methods: A total of 1,206 older hip fracture patients undergoing surgery between January 2013 and December 2022 were consecutively derived from our longitudinal database. Patients were divided into three groups according to SIRI tertiles, calculated as neutrophil × monocyte / lymphocyte. Survival status was obtained from medical records or telephone interviews, and the study outcome was all-cause mortality after hip fracture at the longest follow-up. Multivariate Cox proportional hazard model and restricted cubic spline (RCS) regression model were used to evaluate the association between SIRI and mortality. Moreover, a series of sensitivity analyses were conducted to further validate the robustness of the association.Results: During a median follow-up of 43.85 months, 337 patients (27.94%) died. After full adjustment, each unit increase in SIRI was significantly associated with a 2.2% increase in overall mortality (95% confidence interval [CI]: 1.001–1.042, p = 0.029). Similarly, compared with the first tertile of SIRI, the second and third tertile showed a 1.335-fold (95% CI: 1.011–1.762, p = 0.042) and 1.447-fold (95% CI, 1.093–1.917, p = 0.010) higher risk of death. Sensitivity analyses confirmed the stability of the association. Moreover, RCS analysis revealed a positive non-linear relationship between SIRI and mortality (P for nonlinearity = 0.021).Conclusion: High SIRI level at admission was significantly and positively associated with an increased risk of death, suggesting that SIRI may be an independent predictor of mortality in older patients with hip fracture.
- 22 May 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1401443
Open AccessAssociation of systemic inflammation response index with mortality risk in older patients with hip fracture: a 10-year retrospective cohort study
Objective: With a rapidly aging global population, the assessment of mortality risk following hip fracture in older adults has received increasing attention. Recently, the system inflammation response index (SIRI) has been identified as a novel prognostic marker to reflect both systemic inflammation and immune status. However, it is not yet known whether SIRI is a potential predictor of subsequent death in hip fracture patients. Therefore, this study aimed to investigate the association between SIRI and mortality in older patients with hip fracture.Methods: A total of 1,206 older hip fracture patients undergoing surgery between January 2013 and December 2022 were consecutively derived from our longitudinal database. Patients were divided into three groups according to SIRI tertiles, calculated as neutrophil × monocyte / lymphocyte. Survival status was obtained from medical records or telephone interviews, and the study outcome was all-cause mortality after hip fracture at the longest follow-up. Multivariate Cox proportional hazard model and restricted cubic spline (RCS) regression model were used to evaluate the association between SIRI and mortality. Moreover, a series of sensitivity analyses were conducted to further validate the robustness of the association.Results: During a median follow-up of 43.85 months, 337 patients (27.94%) died. After full adjustment, each unit increase in SIRI was significantly associated with a 2.2% increase in overall mortality (95% confidence interval [CI]: 1.001–1.042, p = 0.029). Similarly, compared with the first tertile of SIRI, the second and third tertile showed a 1.335-fold (95% CI: 1.011–1.762, p = 0.042) and 1.447-fold (95% CI, 1.093–1.917, p = 0.010) higher risk of death. Sensitivity analyses confirmed the stability of the association. Moreover, RCS analysis revealed a positive non-linear relationship between SIRI and mortality (P for nonlinearity = 0.021).Conclusion: High SIRI level at admission was significantly and positively associated with an increased risk of death, suggesting that SIRI may be an independent predictor of mortality in older patients with hip fracture.
- Open Access
- 21 August 2023
- Published by Taylor & Francis in Annals of Medicine
- Vol. 55 (2) , 2249018
High systemic inflammation response index level is associated with an increased risk of lower extremity deep venous thrombosis: a large retrospective study
The association between inflammation and venous thromboembolism (VTE) has attracted increasing research interest. Recently, the systemic inflammation response index (SIRI) has been proposed as a novel inflammatory biomarker, but its potential association with lower extremity deep venous thrombosis (LEDVT) has not been investigated. Thus, this study aimed to explore the association between SIRI and LEDVT risk in a large sample over a 10-year period (2012-2022). All hospitalized patients who underwent lower extremity compression ultrasonography (CUS) examinations were consecutively identified from our hospital information system database. Multivariate logistic regression analysis was used to investigate the association between SIRI and LEDVT risk. Sensitivity, restricted cubic spline and subgroup analyses were also performed. In total, 12643 patients were included, and 1346 (10.6%) LEDVT events occurred. After full adjustment, a higher SIRI level was significantly associated with an increased risk of LEDVT (odds ratio [OR] = 1.098, 95% confidence interval [CI]: 1.068-1.128, p < 0.001), and patients in quartile 4 had a 2.563-fold higher risk of LEDVT than those in quartile 1 (95% CI: 2.064-3.182, p < 0.001). A nonlinear relationship was observed (P for nonlinearity < 0.001), with an inflection point of 4.17. Below this point, each unit increase in SIRI corresponded to a 35.3% increase in LEDVT risk (95% CI: 1.255-1.458, p < 0.001). No significant difference was found above the inflection point (OR = 1.015, 95% CI: 0.963-1.069, p = 0.582). Sensitivity and subgroup analyses confirmed the robustness of the association. This association also existed in both distal and proximal LEDVT. A High SIRI is significantly associated with an increased risk of LEDVT in hospitalized patients. Given that the SIRI is a readily available biomarker in clinical settings, its potential clinical use deserves further exploration.
- 21 August 2023
- Published by Taylor & Francis in Annals of Medicine
- Vol. 55 (2) , 2249018
Open AccessHigh systemic inflammation response index level is associated with an increased risk of lower extremity deep venous thrombosis: a large retrospective study
The association between inflammation and venous thromboembolism (VTE) has attracted increasing research interest. Recently, the systemic inflammation response index (SIRI) has been proposed as a novel inflammatory biomarker, but its potential association with lower extremity deep venous thrombosis (LEDVT) has not been investigated. Thus, this study aimed to explore the association between SIRI and LEDVT risk in a large sample over a 10-year period (2012-2022). All hospitalized patients who underwent lower extremity compression ultrasonography (CUS) examinations were consecutively identified from our hospital information system database. Multivariate logistic regression analysis was used to investigate the association between SIRI and LEDVT risk. Sensitivity, restricted cubic spline and subgroup analyses were also performed. In total, 12643 patients were included, and 1346 (10.6%) LEDVT events occurred. After full adjustment, a higher SIRI level was significantly associated with an increased risk of LEDVT (odds ratio [OR] = 1.098, 95% confidence interval [CI]: 1.068-1.128, p < 0.001), and patients in quartile 4 had a 2.563-fold higher risk of LEDVT than those in quartile 1 (95% CI: 2.064-3.182, p < 0.001). A nonlinear relationship was observed (P for nonlinearity < 0.001), with an inflection point of 4.17. Below this point, each unit increase in SIRI corresponded to a 35.3% increase in LEDVT risk (95% CI: 1.255-1.458, p < 0.001). No significant difference was found above the inflection point (OR = 1.015, 95% CI: 0.963-1.069, p = 0.582). Sensitivity and subgroup analyses confirmed the robustness of the association. This association also existed in both distal and proximal LEDVT. A High SIRI is significantly associated with an increased risk of LEDVT in hospitalized patients. Given that the SIRI is a readily available biomarker in clinical settings, its potential clinical use deserves further exploration.
- Open Access
- 16 June 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1211294
Association between systemic immune-inflammation index and risk of lower extremity deep venous thrombosis in hospitalized patients: a 10-year retrospective analysis
Background: The systemic immune-inflammation index (SII), as a novel inflammatory biomarker, has recently attracted attention in cardiovascular disease research. However, the relationship between SII and risk of lower extremity deep venous thrombosis (LEDVT) remains unclear to date. Thus, this study aimed to explore the association in a large sample over a 10-year period (2012–2022).Methods: All hospitalized patients undergoing lower extremity compression ultrasonography (CUS) examination were consecutively screened by searching our hospital information system database. The receiver operating characteristic (ROC) curve analysis was used to identify the optimal cut-off value for high and low SII group. Multivariate logistic regression analyses were performed to investigate the relationship between SII and LEDVT risk. Propensity score matching (PSM), subgroup and sensitivity analyses were also conducted. Moreover, restricted cubic spline (RCS) regression and two-piecewise linear regression models were used to assess the dose-response relationship between natural log transformed SII [ln(SII)] and risk of LEDVT.Results: A total of 16,725 consecutive hospitalized patients were included, and 1,962 LEDVT events occurred. After adjusting for confounding factors, patients in the high SII group (≥ 574.2 × 109/L) showed a 1.740-fold risk of LEDVT (95% CI: 1.546–1.959, P < 0.001), and elevated ln(SII) was associated with a 36.1% increased risk of LEDVT (95% CI: 1.278–1.449, P < 0.001). PSM, subgroup and sensitivity analyses confirmed the robustness of the association. A non-linear relationship was observed (Pnon−linear < 0.001), with a threshold value of 5.6 × 109/L for all LEDVT events. Above the threshold, each unit increase in ln(SII) had a 1.369-fold higher risk of LEDVT (95% CI: 1.271–1.475, P < 0.001). The association also existed in both distal and proximal LEDVT.Conclusion: Elevated SII is significantly associated with an increased risk of LEDVT in hospitalized patients. Additionally, the association is non-linear and exhibit a threshold effect.
- 16 June 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1211294
Open AccessAssociation between systemic immune-inflammation index and risk of lower extremity deep venous thrombosis in hospitalized patients: a 10-year retrospective analysis
Background: The systemic immune-inflammation index (SII), as a novel inflammatory biomarker, has recently attracted attention in cardiovascular disease research. However, the relationship between SII and risk of lower extremity deep venous thrombosis (LEDVT) remains unclear to date. Thus, this study aimed to explore the association in a large sample over a 10-year period (2012–2022).Methods: All hospitalized patients undergoing lower extremity compression ultrasonography (CUS) examination were consecutively screened by searching our hospital information system database. The receiver operating characteristic (ROC) curve analysis was used to identify the optimal cut-off value for high and low SII group. Multivariate logistic regression analyses were performed to investigate the relationship between SII and LEDVT risk. Propensity score matching (PSM), subgroup and sensitivity analyses were also conducted. Moreover, restricted cubic spline (RCS) regression and two-piecewise linear regression models were used to assess the dose-response relationship between natural log transformed SII [ln(SII)] and risk of LEDVT.Results: A total of 16,725 consecutive hospitalized patients were included, and 1,962 LEDVT events occurred. After adjusting for confounding factors, patients in the high SII group (≥ 574.2 × 109/L) showed a 1.740-fold risk of LEDVT (95% CI: 1.546–1.959, P < 0.001), and elevated ln(SII) was associated with a 36.1% increased risk of LEDVT (95% CI: 1.278–1.449, P < 0.001). PSM, subgroup and sensitivity analyses confirmed the robustness of the association. A non-linear relationship was observed (Pnon−linear < 0.001), with a threshold value of 5.6 × 109/L for all LEDVT events. Above the threshold, each unit increase in ln(SII) had a 1.369-fold higher risk of LEDVT (95% CI: 1.271–1.475, P < 0.001). The association also existed in both distal and proximal LEDVT.Conclusion: Elevated SII is significantly associated with an increased risk of LEDVT in hospitalized patients. Additionally, the association is non-linear and exhibit a threshold effect.
- Open Access
- 22 March 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10
Anatomic distribution of lower extremity deep venous thrombosis is associated with an increased risk of pulmonary embolism: A 10-year retrospective analysis
Aims: To investigate the potential relationship between anatomic distribution of lower extremity deep venous thrombosis (LEDVT) and pulmonary embolism (PE).Methods: A retrospective case-control study was performed in patients diagnosed with LEDVT, which were confirmed by bilateral lower extremity compression ultrasonography (CUS) examination. According to the ultrasound reports, thrombus sidedness was categorized as unilateral and bilateral lower extremity, thrombus location was classified into distal and proximal LEDVT. Anatomic distributions of LEDVT were further subdivided depending on the combination of thrombus sidedness and location. Patients with PE were identified using the International Classification of Diseases-10 (ICD-10) codes (I26.0 and I26.9), and divided into PE group and Non-PE group. Univariate and multivariate logistic regression analyses were used to assess the association between anatomic distribution of LEDVT and PE. Sensitivity analyses were also conducted.Results: A total of 2,363 consecutive patients with LEDVT were included, of whom 66.10% and 33.90% were unilateral and bilateral LEDVT, as well as 71.39% and 28.61% were isolated distal and proximal LEDVT, respectively. After the diagnosis of LEDVT, 185 patients (7.83%) developed PE. The proportions of PE ranged between the lowest (4.07%) in unilateral-distal LEDVT and highest (14.55%) in bilateral-proximal LEDVT. Multivariate logistic regression analysis showed that bilateral LEDVT (odds ratios [OR] = 2.455, 95% confidence interval [CI]: 1.803–3.344, P < 0.001) and proximal LEDVT (OR = 1.530, 95% CI: 1.105–2.118, P = 0.010) were risk factors for developing PE. Moreover, unilateral-proximal (OR = 2.129, 95% CI: 1.365–3.320, P = 0.00), bilateral-distal (OR = 3.193, 95% CI: 2.146–4.752, P < 0.001) and bilateral-proximal LEDVT(OR = 3.425, 95% CI: 2.093–5.603, P < 0.001) were significantly associated with an increased risk of PE. Sensitivity analyses also confirmed the robustness of these associations.Conclusion: Patients with unilateral-proximal, bilateral-distal or bilateral-proximal are more likely to suffer from PE than those with unilateral-distal LEDVT.
- 22 March 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10
Open AccessAnatomic distribution of lower extremity deep venous thrombosis is associated with an increased risk of pulmonary embolism: A 10-year retrospective analysis
Aims: To investigate the potential relationship between anatomic distribution of lower extremity deep venous thrombosis (LEDVT) and pulmonary embolism (PE).Methods: A retrospective case-control study was performed in patients diagnosed with LEDVT, which were confirmed by bilateral lower extremity compression ultrasonography (CUS) examination. According to the ultrasound reports, thrombus sidedness was categorized as unilateral and bilateral lower extremity, thrombus location was classified into distal and proximal LEDVT. Anatomic distributions of LEDVT were further subdivided depending on the combination of thrombus sidedness and location. Patients with PE were identified using the International Classification of Diseases-10 (ICD-10) codes (I26.0 and I26.9), and divided into PE group and Non-PE group. Univariate and multivariate logistic regression analyses were used to assess the association between anatomic distribution of LEDVT and PE. Sensitivity analyses were also conducted.Results: A total of 2,363 consecutive patients with LEDVT were included, of whom 66.10% and 33.90% were unilateral and bilateral LEDVT, as well as 71.39% and 28.61% were isolated distal and proximal LEDVT, respectively. After the diagnosis of LEDVT, 185 patients (7.83%) developed PE. The proportions of PE ranged between the lowest (4.07%) in unilateral-distal LEDVT and highest (14.55%) in bilateral-proximal LEDVT. Multivariate logistic regression analysis showed that bilateral LEDVT (odds ratios [OR] = 2.455, 95% confidence interval [CI]: 1.803–3.344, P < 0.001) and proximal LEDVT (OR = 1.530, 95% CI: 1.105–2.118, P = 0.010) were risk factors for developing PE. Moreover, unilateral-proximal (OR = 2.129, 95% CI: 1.365–3.320, P = 0.00), bilateral-distal (OR = 3.193, 95% CI: 2.146–4.752, P < 0.001) and bilateral-proximal LEDVT(OR = 3.425, 95% CI: 2.093–5.603, P < 0.001) were significantly associated with an increased risk of PE. Sensitivity analyses also confirmed the robustness of these associations.Conclusion: Patients with unilateral-proximal, bilateral-distal or bilateral-proximal are more likely to suffer from PE than those with unilateral-distal LEDVT.
- 17 September 2022
- Published by Elsevier in Journal of Cleaner Production
- Vol. 375, 134106
Evaluation of the control effect of bighead carp and silver carp on cyanobacterial blooms based on the analysis of differences in algal digestion processes
- 17 September 2022
- Published by Elsevier in Journal of Cleaner Production
- Vol. 375, 134106
Evaluation of the control effect of bighead carp and silver carp on cyanobacterial blooms based on the analysis of differences in algal digestion processes
- Open Access
- 16 September 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 184, 141-146
Muscular Calf Vein Thrombosis Is Associated With Increased 30-Day Mortality But Not 90-Day Mortality in Older Patients With Hip Fracture
- 16 September 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 184, 141-146
Open AccessMuscular Calf Vein Thrombosis Is Associated With Increased 30-Day Mortality But Not 90-Day Mortality in Older Patients With Hip Fracture
- 28 September 2020
- Published by Springer Nature in International Orthopaedics
- Vol. 45 (1) , 13-21
High platelet-to-lymphocyte ratio predicts poor survival of elderly patients with hip fracture
Purpose The platelet-to-lymphocyte ratio (PLR) has been extensively studied in various diseases. However, the relationship between PLR and hip fracture remains unknown. The aim of this study was to evaluate whether PLR would be an independent prognostic factor in elderly hip fracture patients. Methods Between January 2014 and December 2018, a retrospective cohort study was conducted in a orthopaedic centre, China. A total of 460 hip fracture patients were included. PLR was calculated as the ratio of platelet to lymphocyte counts and divided into high PLR group (≥ 189) and low PLR group (< 189) by using the receiver operating characteristic (ROC) curve. The relationship between PLR and one year all-cause mortality rate was assessed by univariate and multivariate Cox proportional hazard models. Further subgroup analysis stratified by different clinical and biological characteristics was performed to make the results more accurate. Results After a median follow-up of 32.0 months (range, 12.0–75.4), 92 patients (mortality rate: 20.0%) died within one year. PLR was significantly higher in dead patients compared with alive patients (p < 0.05), and high PLR group also had a high mortality rate (32.21% vs. 14.15%, p < 0.001). After multivariate adjustment, high PLR remained an independent predictor for one year all-cause mortality (adjusted hazard ratio (HR) 1.56, 95% confidence interval (CI) 1.02–2.41, p = 0.041). Moreover, advanced age (HR 1.05, 95% CI 1.01–1.08), male (HR 1.62, 95% CI 1.06–2.45), CCI ≥ 2 (HR 2.83, 95% CI 1.64–4.89), conservative treatment (HR 5.94, 95% CI 3.71–9.73), low haemoglobin level (HR 1.02, 95% CI 1.01–1.04), and low albumin level (HR 1.07, 95% CI 1.02–1.13) were independent risk factors for survival. Furthermore, subgroup analysis results were consistent with the main findings in most stratified groups. Conclusion This study highlights that high PLR (≥ 189) is associated with increased one year all-cause mortality in elderly hip fracture patients. As PLR is a simple indicator that can be calculated from the blood routine test, it can be easily performed in usual clinical practice.
- 28 September 2020
- Published by Springer Nature in International Orthopaedics
- Vol. 45 (1) , 13-21
High platelet-to-lymphocyte ratio predicts poor survival of elderly patients with hip fracture
Purpose The platelet-to-lymphocyte ratio (PLR) has been extensively studied in various diseases. However, the relationship between PLR and hip fracture remains unknown. The aim of this study was to evaluate whether PLR would be an independent prognostic factor in elderly hip fracture patients. Methods Between January 2014 and December 2018, a retrospective cohort study was conducted in a orthopaedic centre, China. A total of 460 hip fracture patients were included. PLR was calculated as the ratio of platelet to lymphocyte counts and divided into high PLR group (≥ 189) and low PLR group (< 189) by using the receiver operating characteristic (ROC) curve. The relationship between PLR and one year all-cause mortality rate was assessed by univariate and multivariate Cox proportional hazard models. Further subgroup analysis stratified by different clinical and biological characteristics was performed to make the results more accurate. Results After a median follow-up of 32.0 months (range, 12.0–75.4), 92 patients (mortality rate: 20.0%) died within one year. PLR was significantly higher in dead patients compared with alive patients (p < 0.05), and high PLR group also had a high mortality rate (32.21% vs. 14.15%, p < 0.001). After multivariate adjustment, high PLR remained an independent predictor for one year all-cause mortality (adjusted hazard ratio (HR) 1.56, 95% confidence interval (CI) 1.02–2.41, p = 0.041). Moreover, advanced age (HR 1.05, 95% CI 1.01–1.08), male (HR 1.62, 95% CI 1.06–2.45), CCI ≥ 2 (HR 2.83, 95% CI 1.64–4.89), conservative treatment (HR 5.94, 95% CI 3.71–9.73), low haemoglobin level (HR 1.02, 95% CI 1.01–1.04), and low albumin level (HR 1.07, 95% CI 1.02–1.13) were independent risk factors for survival. Furthermore, subgroup analysis results were consistent with the main findings in most stratified groups. Conclusion This study highlights that high PLR (≥ 189) is associated with increased one year all-cause mortality in elderly hip fracture patients. As PLR is a simple indicator that can be calculated from the blood routine test, it can be easily performed in usual clinical practice.